Interaction between phenytoin and antacids.

Abstract

British Journal of Clinical PharmacologyVolume 6, Issue 2 p. 177-179 Free Access Interaction between phenytoin and antacids. VK Kulshrestha, VK KulshresthaSearch for more papers by this authorM Thomas, M ThomasSearch for more papers by this authorJ Wadsworth, J WadsworthSearch for more papers by this authorA Richens, A RichensSearch for more papers by this author VK Kulshrestha, VK KulshresthaSearch for more papers by this authorM Thomas, M ThomasSearch for more papers by this authorJ Wadsworth, J WadsworthSearch for more papers by this authorA Richens, A RichensSearch for more papers by this author First published: August 1978 https://doi.org/10.1111/j.1365-2125.1978.tb00848.xCitations: 20AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References AMBRE, J.J. & FISCHER, L.J. (1973). Effect of coadministration of aluminium and magnesium hydroxide on absorption of anticoagulants in man. Clin. Pharmac. Ther., 14, 231– 237. BOCHNER, F., HOOPER, W.D., TYRER, J.H. & EADIE, M.J. (1972). Factors involved in an outbreak of phenytoin intoxication. J. Neurol. Scand., 16, 481– 487. BROWN, O.D. & JUHL, R.P. (1976). Decreased bioavailability of digoxin due to antacids and kaolin-pectin. New Eng. J. Med., 295, 1034– 1037. CASPARY, W.F. (1972). Inhibition of intestinal calcium transport by diphenylhydantoin in rat duodenum. Naunym. Schmiedebergs Arch. exp. Path. Pharmak., 274, 146– 153. FANN, W.E., DAVIES, J.M., JANOWSKI, D.S., SEKERKE, H.J. & SCHMIDT, D. (1973). Chlorpromazine: effects of antacids on its gastrointestinal absorption. J. clin. Pharmac., 13, 388– 390. GLAZKO, A.J. & CHANG, T. (1972). Diphenylhydantoin: absorption, distribution and excretion. In Antiepileptic Drugs D.M. Woodbury, J.K. Penry & R.P. Schmidt pp. 127– 136.New York: Raven Press. GREENBLATT, D.J., SHADER, R.I., HARMATZ, J.S., FRANKE, K. & KOCH-WESER, J. (1976). Influences of magnesium and aluminium hydroxide mixture on chlordiazepoxide absorption. Clin. Pharmac. Ther., 19, 234– 239. HOUGHTON, G.W. & RICHENS, A. (1974). Inhibition of phenytoin metabolism by sulthiame in epileptic patients. Br. J. clin. Pharmac., 1, 59– 66. KUNIN, C.M. & FINLAND, M. (1961). Clinical pharmacology of the tetracycline antibiotics. Clin. Pharmac. Ther., 2, 51. KUTT, H. (1975). Interactions of antiepileptic drugs. Epilepsia (N.Y.), 16, 393– 402. REES, H. van & ROACH, E.L. (1973). The intestinal absorption of diphenylhydantoin from a suspension in rats. Arch. int. Pharmacodyn. Ther., 206, 76– 83. RICHENS, A. (1977). Interactions with antiepileptic drugs. Drugs, 13, 266– 275. RICHENS, A. & DUNLOP, A. (1975). Serum phenytoin levels in the management of epilepsy. Lancet, ii, 247– 248. WAISBREN, B.A. & HUECKEL, J.S. (1950). Reduced absorption of aureomycin caused by aluminium hydroxide gel. Proc. Soc. exp. Biol. Med., 73, 73– 74. Citing Literature Volume6, Issue2August 1978Pages 177-179 ReferencesRelatedInformation